$CRM
Salesforce, Inc.

2020 Q2 Form 10-Q Financial Statement

#000110852422000007 Filed on June 01, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $4.865B $3.737B
YoY Change 30.18% 24.32%
Cost Of Revenue $1.254B $914.0M
YoY Change 37.2% 19.17%
Gross Profit $3.611B $2.823B
YoY Change 27.91% 26.08%
Gross Profit Margin 74.22% 75.54%
Selling, General & Admin $2.892B $2.059B
YoY Change 40.46% 26.79%
% of Gross Profit 80.09% 72.94%
Research & Development $859.0M $554.0M
YoY Change 55.05% 30.66%
% of Gross Profit 23.79% 19.62%
Depreciation & Amortization $658.0M $437.0M
YoY Change 50.57% 141.44%
% of Gross Profit 18.22% 15.48%
Operating Expenses $3.751B $2.613B
YoY Change 43.55% 27.59%
Operating Profit -$140.0M $210.0M
YoY Change -166.67% 9.95%
Interest Expense $195.0M $272.0M
YoY Change -28.31% 700.0%
% of Operating Profit 129.52%
Other Income/Expense, Net -$5.000M -$9.000M
YoY Change -44.44% -47.06%
Pretax Income $47.00M $482.0M
YoY Change -90.25% 25.19%
Income Tax -$52.00M $90.00M
% Of Pretax Income -110.64% 18.67%
Net Earnings $99.00M $392.0M
YoY Change -74.74% 13.95%
Net Earnings / Revenue 2.03% 10.49%
Basic Earnings Per Share $0.11 $0.51
Diluted Earnings Per Share $0.11 $0.49
COMMON SHARES
Basic Shares Outstanding 896.0M shares 771.0M shares
Diluted Shares Outstanding 913.0M shares 793.0M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.802B $6.379B
YoY Change 53.66% -10.9%
Cash & Equivalents $5.772B $4.110B
Short-Term Investments $4.030B $2.269B
Other Short-Term Assets $954.0M $717.0M
YoY Change 33.05% 35.8%
Inventory
Prepaid Expenses
Receivables $3.076B $2.153B
Other Receivables $0.00 $0.00
Total Short-Term Assets $14.71B $10.04B
YoY Change 46.62% -1.14%
LONG-TERM ASSETS
Property, Plant & Equipment $2.518B $2.243B
YoY Change 12.26% 15.03%
Goodwill $25.27B $12.85B
YoY Change 96.56% 72.68%
Intangibles $4.488B $1.794B
YoY Change 150.17% 120.12%
Long-Term Investments $1.902B $1.548B
YoY Change 22.87% 51.17%
Other Assets $582.0M $677.0M
YoY Change -14.03% 72.7%
Total Long-Term Assets $38.91B $23.12B
YoY Change 68.3% 80.45%
TOTAL ASSETS
Total Short-Term Assets $14.71B $10.04B
Total Long-Term Assets $38.91B $23.12B
Total Assets $53.62B $33.15B
YoY Change 61.74% 44.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.916B $2.050B
YoY Change 42.24% 1429.85%
Accrued Expenses $742.0M $675.0M
YoY Change 9.93% -16.56%
Deferred Revenue $9.112B $7.585B
YoY Change 20.13% 22.32%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.000M $4.000M
YoY Change 0.0% 33.33%
Total Short-Term Liabilities $12.84B $10.49B
YoY Change 22.45% 32.84%
LONG-TERM LIABILITIES
Long-Term Debt $2.673B $3.173B
YoY Change -15.76% 0.03%
Other Long-Term Liabilities $1.120B $664.0M
YoY Change 68.67% -20.57%
Total Long-Term Liabilities $3.793B $3.837B
YoY Change -1.15% -4.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.84B $10.49B
Total Long-Term Liabilities $3.793B $3.837B
Total Liabilities $19.06B $16.71B
YoY Change 14.07% 40.37%
SHAREHOLDERS EQUITY
Retained Earnings $1.960B $2.127B
YoY Change -7.85% 119.5%
Common Stock $32.74B $14.38B
YoY Change 127.61% 42.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.57B $16.45B
YoY Change
Total Liabilities & Shareholders Equity $53.62B $33.15B
YoY Change 61.74% 44.38%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $99.00M $392.0M
YoY Change -74.74% 13.95%
Depreciation, Depletion And Amortization $658.0M $437.0M
YoY Change 50.57% 141.44%
Cash From Operating Activities $1.859B $1.965B
YoY Change -5.39% 34.04%
INVESTING ACTIVITIES
Capital Expenditures $323.0M $159.0M
YoY Change 103.14% 30.33%
Acquisitions $103.0M $10.00M
YoY Change 930.0% -94.51%
Other Investing Activities -$114.0M -$567.0M
YoY Change -79.89% -242.46%
Cash From Investing Activities -$437.0M -$726.0M
YoY Change -39.81% -363.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $209.0M $207.0M
YoY Change 0.97% -87.26%
NET CHANGE
Cash From Operating Activities $1.859B $1.965B
Cash From Investing Activities -$437.0M -$726.0M
Cash From Financing Activities $209.0M $207.0M
Net Change In Cash $1.627B $1.441B
YoY Change 12.91% -57.35%
FREE CASH FLOW
Cash From Operating Activities $1.859B $1.965B
Capital Expenditures $323.0M $159.0M
Free Cash Flow $1.536B $1.806B
YoY Change -14.95% 34.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 dei Amendment Flag
AmendmentFlag
false
CY2020Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001108524
CY2020Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Purchase Period
SharebasedCompensationArrangementbySharebasedPaymentAwardPurchasePeriod
P6M
CY2020Q2 dei Document Type
DocumentType
10-Q
CY2020Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 dei Document Period End Date
DocumentPeriodEndDate
2020-04-30
CY2020Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity File Number
EntityFileNumber
001-32224
CY2020Q2 dei Entity Registrant Name
EntityRegistrantName
salesforce.com, inc.
CY2020Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3320693
CY2020Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
Salesforce Tower
CY2020Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
415 Mission Street, 3rd Fl
CY2020Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2020Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2020Q2 dei City Area Code
CityAreaCode
415
CY2020Q2 dei Local Phone Number
LocalPhoneNumber
901-7000
CY2020Q2 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020Q2 dei Trading Symbol
TradingSymbol
CRM
CY2020Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q2 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
901000000 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5772000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4145000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
4030000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3802000000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3076000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6174000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
881000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
926000000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
954000000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
916000000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
14713000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
15963000000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2518000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2375000000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2983000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3040000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1171000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1348000000 USD
CY2020Q2 us-gaap Other Long Term Investments
OtherLongTermInvestments
1902000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
25266000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4488000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4724000000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
582000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
579000000 USD
CY2020Q2 us-gaap Assets
Assets
53623000000 USD
CY2020Q1 us-gaap Assets
Assets
55126000000 USD
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2989000000 USD
CY2020Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3433000000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
742000000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
750000000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9112000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12843000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14845000000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2422000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2445000000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1120000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1278000000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
19058000000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
21241000000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1000000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32739000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32116000000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-135000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-93000000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1960000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1861000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
34565000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53623000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55126000000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4865000000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3737000000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1254000000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
914000000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
3611000000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
2823000000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
859000000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
554000000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2390000000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1697000000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
502000000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
362000000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
3751000000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
2613000000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-140000000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
210000000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
192000000 USD
CY2019Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
281000000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47000000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
482000000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-52000000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
896000000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
771000000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
913000000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
793000000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-23000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-13000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-25000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
8000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-48000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-5000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-6000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57000000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
385000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
15605000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
113000000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
343000000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
16446000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33885000000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119000000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
504000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
34565000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
658000000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
437000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
247000000 USD
CY2019Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
209000000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
504000000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
343000000 USD
CY2020Q2 crm Marketable Equityand Non Marketable Debtand Equity Securities Realized Gains Losson Sale
MarketableEquityandNonMarketableDebtandEquitySecuritiesRealizedGainsLossonSale
192000000 USD
CY2019Q2 crm Marketable Equityand Non Marketable Debtand Equity Securities Realized Gains Losson Sale
MarketableEquityandNonMarketableDebtandEquitySecuritiesRealizedGainsLossonSale
281000000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3094000000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2774000000 USD
CY2020Q2 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
25000000 USD
CY2019Q2 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
124000000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11000000 USD
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
97000000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
147000000 USD
CY2019Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15000000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-904000000 USD
CY2019Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-560000000 USD
CY2020Q2 crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
203000000 USD
CY2019Q2 crm Increase Decreasein Operating Lease Liabilities
IncreaseDecreaseinOperatingLeaseLiabilities
164000000 USD
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1555000000 USD
CY2019Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-979000000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1859000000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1965000000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
103000000 USD
CY2019Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10000000 USD
CY2020Q2 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
342000000 USD
CY2019Q2 crm Payments For Investments In Privately Held Companies
PaymentsForInvestmentsInPrivatelyHeldCompanies
159000000 USD
CY2020Q2 crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
601000000 USD
CY2019Q2 crm Proceeds From Investments In Privately Held Companies
ProceedsFromInvestmentsInPrivatelyHeldCompanies
194000000 USD
CY2020Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
834000000 USD
CY2019Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
734000000 USD
CY2020Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
337000000 USD
CY2019Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
86000000 USD
CY2020Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
227000000 USD
CY2019Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
56000000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
323000000 USD
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
159000000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-437000000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-726000000 USD
CY2020Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
258000000 USD
CY2019Q2 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
219000000 USD
CY2020Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
48000000 USD
CY2019Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
11000000 USD
CY2020Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1000000 USD
CY2019Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1000000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
209000000 USD
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207000000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000 USD
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1627000000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1441000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4145000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2669000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5772000000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4110000000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
46000000 USD
CY2019Q2 us-gaap Interest Paid Net
InterestPaidNet
50000000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
58000000 USD
CY2019Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18000000 USD
CY2020Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on January 31. References to fiscal 2021, for example, refer to the fiscal year ending January 31, 2021.</span></div>
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions in the Company’s condensed consolidated financial statements and notes thereto.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates and assumptions made by management include the determination of:</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the fair value of assets acquired and liabilities assumed for business combinations;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the standalone selling price (“SSP”) of performance obligations for revenue contracts with multiple performance obligations;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the valuation of privately-held strategic investments, including impairments;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions;</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the average period of benefit associated with costs capitalized to obtain revenue contracts; </span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the useful lives of intangible assets; and</span></div><div style="margin-top:3.25pt;padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the fair value of certain stock awards issued.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the result of which forms the basis for making judgments about the carrying values of assets and liabilities. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the novel coronavirus and resulting disease (“COVID-19”) was reported and in March 2020 the World Health Organization declared it a pandemic. The extent of the impact of COVID-19 on the Company’s operational and financial performance will depend on certain developments, including the duration of the outbreak, impact on the Company’s </span></div>customers and its sales cycles, and impact on the Company’s employees, as discussed in more detail in Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. During the three months ended April 30, 2020, this uncertainty resulted in a higher level of judgment related to the Company’s estimates and assumptions concerning variable consideration related to revenue recognition, allowances for credit losses, impairment of strategic investments, contract termination costs related to customer and employee events and operating lease right of use assets impairment. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require it to update its estimates, judgments, or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and such changes will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from these estimates and any such differences may be material to the Company’s financial statements.
CY2020Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk, Significant Customers and Investments</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. Collateral is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. Receivables are written-off and charged against the recorded allowance when the Company has exhausted collection efforts without success. </span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than five percent of accounts receivable at April 30, 2020 and January 31, 2020. No single customer accounted for five percent or more of total revenue during the three months ended April 30, 2020 and 2019. As of April 30, 2020 and January 31, 2020, assets located outside the Americas were 11 percent and 12 percent of total assets, respectively. As of April 30, 2020 and January 31, 2020, assets located in the United States were 87 percent and 87 percent of total assets, respectively.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also exposed to concentrations of risk in its strategic investment portfolio. As of April 30, 2020, the Company held five investments with carrying values that were individually greater than five percent of its total strategic investments, all of which were privately held. As of January 31, 2020, the Company held five investments that were individually greater than five percent of its total strategic investments, of which one was publicly traded and four were privately held.</span></div>
CY2020Q2 crm Percent Of Total Strategic Investments
PercentOfTotalStrategicInvestments
0.05
CY2020Q1 crm Number Of Investments Held
NumberOfInvestmentsHeld
5 investment
CY2020Q1 crm Percent Of Total Strategic Investments
PercentOfTotalStrategicInvestments
0.05
CY2020Q1 crm Number Of Publicly Traded Investments Held
NumberOfPubliclyTradedInvestmentsHeld
1 investment
CY2020Q1 crm Number Of Privately Held Investments
NumberOfPrivatelyHeldInvestments
4 investment
CY2020Q2 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2020Q2 crm Capitalized Contract Cost Renewalsand Success Fees Amortization Term
CapitalizedContractCostRenewalsandSuccessFeesAmortizationTerm
P2Y
CY2020Q2 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
25000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
247000000 USD
CY2019Q2 crm Increase Decreasein Capitalized Contract Costs
IncreaseDecreaseinCapitalizedContractCosts
124000000 USD
CY2019Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
209000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2100000000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
2300000000 USD
CY2020Q2 crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
CY2019Q2 crm Impairments Of Costs To Obtain Revenue Contracts
ImpairmentsOfCostsToObtainRevenueContracts
0 USD
CY2019Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2019Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2020Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2019Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Award Offering Period
SharebasedCompensationArrangementbySharebasedPaymentAwardAwardOfferingPeriod
P12M
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.15
CY2020Q2 crm Percentageof Tax Benefit Likely To Be Realized Upon Settlement
PercentageofTaxBenefitLikelyToBeRealizedUponSettlement
0.50
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4865000000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3737000000 USD
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
454000000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
449000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10662000000 USD
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8564000000 USD
CY2020Q2 crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
3305000000 USD
CY2019Q2 crm Contractwith Customer Liability Billingsand Other
ContractwithCustomerLiabilityBillingsandOther
2714000000 USD
CY2020Q2 crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
5000000 USD
CY2019Q2 crm Contractwith Customer Liability Contributionfrom Contract Asset
ContractwithCustomerLiabilityContributionfromContractAsset
44000000 USD
CY2020Q2 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
5000000 USD
CY2019Q2 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
0 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9112000000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7585000000 USD
CY2020Q2 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
14500000000 USD
CY2020Q2 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
14800000000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
29300000000 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Current
RevenueRemainingPerformanceObligationCurrent
15000000000.0 USD
CY2020Q1 crm Revenue Remaining Performance Obligation Noncurrent
RevenueRemainingPerformanceObligationNoncurrent
15800000000 USD
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30800000000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4041000000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
21000000 USD
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
32000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4030000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3789000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1293000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1332000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2721000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2466000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
16000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4000000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4030000000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3802000000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1822000000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
32000000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1822000000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
32000000 USD
CY2020Q2 crm Unrealized Losses On Fixed Rate Investments Lower Range Value
UnrealizedLossesOnFixedRateInvestmentsLowerRangeValue
1000000 USD
CY2020Q2 crm Unrealized Losses On Fixed Rate Investments Upper Range Value
UnrealizedLossesOnFixedRateInvestmentsUpperRangeValue
2000000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
26000000 USD
CY2020Q2 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1000000 USD
CY2019Q2 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 USD
CY2020Q2 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1000000 USD
CY2019Q2 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
28000000 USD
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
26000000 USD
CY2020Q2 us-gaap Other Long Term Investments
OtherLongTermInvestments
1902000000 USD
CY2020Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
1963000000 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1502000000 USD
CY2019Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
785000000 USD
CY2020Q2 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
265000000 USD
CY2019Q2 crm Strategic Investments Net Additions Reductions
StrategicInvestmentsNetAdditionsReductions
20000000 USD
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
30000000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
140000000 USD
CY2020Q2 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
66000000 USD
CY2019Q2 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Annual Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentAnnualAmount
18000000 USD
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1731000000 USD
CY2019Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
927000000 USD
CY2020Q2 crm Equity Securitieswithout Readily Determinable Fair Value Impairment Lossand Downward Price Adjustment Cumulative Amount
EquitySecuritieswithoutReadilyDeterminableFairValueImpairmentLossandDownwardPriceAdjustmentCumulativeAmount
168000000 USD
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
484000000 USD
CY2020Q2 crm Gain Losson Strategic Investments
GainLossonStrategicInvestments
192000000 USD
CY2019Q2 crm Gain Losson Strategic Investments
GainLossonStrategicInvestments
281000000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
359000000 USD
CY2020Q2 crm Number Of Publicly Traded Investments Sold
NumberOfPubliclyTradedInvestmentsSold
2 investment
CY2020Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-47000000 USD
CY2020Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
77000000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
7517000000 USD
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
73000000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6239000000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24000000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
24000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6922000000 USD
CY2020Q2 crm Finitelived Intangible Assets Additionsand Retirements Net
FinitelivedIntangibleAssetsAdditionsandRetirementsNet
35000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6957000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2198000000 USD
CY2020Q2 crm Finitelived Intangible Assets Amortization Expenseand Retirements Net
FinitelivedIntangibleAssetsAmortizationExpenseandRetirementsNet
271000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2469000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4724000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4488000000 USD
CY2020Q2 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y1M6D
CY2020Q2 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
271000000 USD
CY2019Q2 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
129000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
798000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
995000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
840000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
752000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
516000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
587000000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4488000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
25134000000 USD
CY2020Q2 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
58000000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
25266000000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2677000000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2677000000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4000000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2673000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
4000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1182000000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1500000000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
2693000000 USD
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
24000000 USD
CY2019Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
28000000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000 USD
CY2019Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
29000000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
150000000 USD
CY2020Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
900000000 USD
CY2020Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1500000000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.67
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.82
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27000000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
98.56
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
6000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
154.23
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
62.67
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
111.82
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1542000000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
28000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
108.78
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1509000000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
14000000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
77.73
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1201000000 USD
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
31000000 shares
CY2020Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y10M24D
CY2020Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
111.82
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
14000000 shares
CY2020Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
77.73
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
504000000 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Remainingof Fiscal Year
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationRemainingofFiscalYear
1638000000 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Two
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearTwo
1684000000 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Three
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearThree
1219000000 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Four
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearFour
630000000 USD
CY2020Q2 crm Sharebased Compensation Arrangementby Sharebased Payment Award Amortization Year Five
SharebasedCompensationArrangementbySharebasedPaymentAwardAmortizationYearFive
94000000 USD
CY2020Q2 crm Share Based Compensation Arrangement By Share Based Payment Award Amortization Thereafter
ShareBasedCompensationArrangementByShareBasedPaymentAwardAmortizationThereafter
3000000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5268000000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
115000000 shares
CY2020Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
133000000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
896000000 shares
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-52000000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47000000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.11
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
482000000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19
CY2020Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
17000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
99000000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
392000000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
771000000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17000000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
913000000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
793000000 shares
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q2 crm Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
279000000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
206000000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
226000000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
189000000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.027
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P18Y
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
24000000 USD
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.045
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
618000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
49000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
665000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
23000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
490000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
23000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
371000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
301000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1054000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
410000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3499000000 USD
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
553000000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
335000000 USD
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
182000000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3164000000 USD
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
371000000 USD
CY2020Q2 crm Lessor Operating Lease Payments To Be Received Next Five Years
LessorOperatingLeasePaymentsToBeReceivedNextFiveYears
187000000 USD
CY2020Q2 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
49000000 USD
CY2020Q2 crm Lessee Operating Lease Lease Notyet Commenced Amount
LesseeOperatingLeaseLeaseNotyetCommencedAmount
2400000000 USD
CY2020Q2 crm Lessee Operating Lease Commitmentincluding Lease Notyet Commenced Amount
LesseeOperatingLeaseCommitmentincludingLeaseNotyetCommencedAmount
5900000000 USD

Files In Submission

Name View Source Status
0001108524-22-000007-index-headers.html Edgar Link pending
0001108524-22-000007-index.html Edgar Link pending
0001108524-22-000007.txt Edgar Link pending
0001108524-22-000007-xbrl.zip Edgar Link pending
crm-20200430.htm Edgar Link pending
crm-20200430.xsd Edgar Link pending
crm-20200430_cal.xml Edgar Link unprocessable
crm-20200430_def.xml Edgar Link unprocessable
crm-20200430_g1.jpg Edgar Link pending
crm-20200430_g2.jpg Edgar Link pending
crm-20200430_g3.jpg Edgar Link pending
crm-20200430_g4.jpg Edgar Link pending
crm-20200430_htm.xml Edgar Link completed
crm-20200430_lab.xml Edgar Link unprocessable
crm-20200430_pre.xml Edgar Link unprocessable
ex311-ceocertq1fy21.htm Edgar Link pending
ex312-cfocertq1fy21.htm Edgar Link pending
ex321-soxcertsq1fy21.htm Edgar Link pending
exhibit102-blocktransition.htm Edgar Link pending
exhibit103-aircrafttimesha.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending